Jonathan N. Byrd, MD works in the field of Internal Medicine. He studied medicine at Washington University School of Medicine in St. Louis. Jonathan Byrd is a published MD as well. He has 1 publication published. The latest was: The neurofibromatosis type 1 tumor suppressor controls cell growth by regulating signal transducer and activator of transcription-3 activity in vitro and in vivo.
NPI NUMBER | 1063707966 | |
NPPES Provider LastName | BYRD | |
NPPES Provider FirstName | JONATHAN | |
NPPES Provider ZIPCode | 631082102 | |
NPPES Provider State | MO | |
Specialty Description | Internal Medicine | |
Total Claim Count | 437.0 | |
Distinct Opioid Count | 0.0 | |
Opioid Claim Count | 0.0 | |
Percent Opioid Claims | 0.0 |
National Provider Identifier [NPI] | 1063707966 |
Last Name Of The Provider | BYRD |
First Name Of The Provider | JONATHAN |
View All |
![]() |
Dr. Rafi T. Kevorkian, MD
![]() ![]() |
![]() |
Dr. Johnny T. Lu, MD |
![]() |
Dr. Bryan P. Burns, DO
![]() |
![]() |
Dr. Naveen K. Bondalapati, MD
![]() |
![]() |
Dr. Yevgeniy Khariton, MD |
![]() |
Dr. David A. Katzman, MD
![]() |
![]() |
Dr. Salik K. Choudhary, MD
![]() |
![]() |
Susan L. Gordon |
![]() |
Dr. Peter A. Riedell, MD
![]() |